Evaluates the efficacy of doxycycline nanocarriers in managing topical bacterial infections, suggesting improved treatment options.
Bacterial infection poses a significant challenge in many critical chronic skin infections, such as diabetic wounds and multidrug-resistant infections. The present study aims to optimise doxycycline hyclate-loaded herbal oil-based nanoemulsion. Various formulations were prepared according to the Box Behnken Design, and particle size, polydispersity index (PDI) and zetapotential were analysed. A stable optimised formulation was loaded in Carbopol 974 (0.5-1.5%) nanoemulgel and evaluated for appearance, viscosity, drug content, and drug release. The best formulation was evaluated for ex-vivo permeation efficiency and skin penetration by Confocal Laser Scanning Microscopy. The optimised nanoemulsion was found to have a particle size of 24.04 nm, Zeta potential – 10.86mV, and PDI 0.1847. In-vitro drug release studies showed a sustained release pattern over 24 h and followed the Higuchi model (R2 = 0.80) release kinetics. Ex vivo skin permeation studies revealed that DH-NEG permeates through the membrane at 2.7954 µg/cm²/hr, and the conventional gel permeates 1.56 µg/cm²/hr. The study concluded that the optimised DH-loaded nanoemulgel formulation has promising application due to its enhanced permeation ability, improved physicochemical stability and above all, it has a sustained drug release profile. The therapeutic efficacy of DH will be improved by the presence of cinnamon oil.
No takes yet. Share an insight, caveat, or question.
Bhamboo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: